Draft:SDMA
| Submission declined on 20 April 2024 by Stuartyeates (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: A parent is a primary source and not usable in a tertiary source. We need independent secondary sources. Stuartyeates (talk) 09:27, 20 April 2024 (UTC)
- Comment: The title of this draft either has been disambiguated or will need to be disambiguated for acceptance.If this draft is accepted, the disambiguation page will need to be edited. Either an entry will need to be added, or an entry will need to be revised. The disambiguation page for the primary name is SDMA (disambiguation).What does the SDMA stand for? Robert McClenon (talk) 18:34, 19 April 2024 (UTC)
.gif) | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| Chemical and physical data | |
| Formula | C11H15NOS |
| Molar mass | 209.31 g·mol−1 |
| 3D model (JSmol) | |
| |
SDMA (Benzoxathiol-6-yl-N-methyl-propan-2-amine) is a substituted amphetamine derivative with empathogenic effects, which acts as analogue of MDMA with a supposed shorter half-life. SDMA, along with its corresponding nor-compound SDA, are potential candidates for treatment-resistant depression and post-traumatic stress disorder. New SDMA prodrugs are in the development phase at MiHKAL GmbH in Switzerland.[1]
.gif)
References[edit]
- ^ Grill M (21 March 2024). "Grill M, "Novel nootropic prodrugs of Phenethylamine", published 21 March 2024".